Literature DB >> 17526965

May thrombosis be a cause of congenital extremity absence?

Gurkan Genc1, Nilgun Erkek Atay, Eda Kepenekli, Nese Yarali.   

Abstract

Congenital extremity anomalies have many modes of presentation. Interruption of vascular supply with thrombophily is a rare cause of congenital extremity absence. Here it is presented a 7 mth old male with absence of the left lower extremity. Laboratory tests revealed Factor V Leiden and Prothrombin G20210A heterozygote mutation and that was as the cause of extremity absence. At the patients with congenital extremity absences, it is not imprudent to explore a possible thrombophilic mutation along with other known etiologic factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526965     DOI: 10.1007/s12098-007-0086-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  13 in total

1.  Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis.

Authors:  A Gürgey; G Hicsönmez; H Parlak; G Balta; A Celiker
Journal:  Am J Hematol       Date:  1998-10       Impact factor: 10.047

2.  The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey.

Authors:  A Gürgey; L Mesci
Journal:  Turk J Pediatr       Date:  1997 Jul-Sep       Impact factor: 0.552

3.  Prevalence of factor V Leiden and prothrombin G20210A gene mutation.

Authors:  Ahmet Irdem; Celal Devecioglu; Sabri Batun; Murat Soker; Iclal A Sucakli
Journal:  Saudi Med J       Date:  2005-04       Impact factor: 1.484

Review 4.  Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Möbius anomalies.

Authors:  J N Bavinck; D D Weaver
Journal:  Am J Med Genet       Date:  1986-04

5.  Early occlusion of coronary by-pass associated with the presence of factor V Leiden and the prothrombin 20210A allele: case report.

Authors:  M L Varela; Y P Adamczuk; M E Martinuzzo; R R Forastiero; F R Klein; A S Rossi; L O Carreras
Journal:  Blood Coagul Fibrinolysis       Date:  1999-10       Impact factor: 1.276

6.  Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Authors:  J Emmerich; F R Rosendaal; M Cattaneo; M Margaglione; V De Stefano; T Cumming; V Arruda; A Hillarp; J L Reny
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

7.  Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.

Authors:  A Gurgey; I C Haznedaroglu; T Egesel; Y Buyukasik; O I Ozcebe; N Sayinalp; S V Dundar; Y Bayraktar
Journal:  Am J Hematol       Date:  2001-06       Impact factor: 10.047

Review 8.  Haemostatic gene polymorphisms in venous and arterial thrombosis.

Authors:  David A Lane; Luigina R Mollica
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Sep-Dec

9.  Multiple arterial thrombi and in utero leg gangrene in an infant of a diabetic mother.

Authors:  Denise K Long; Diane E Lorant
Journal:  J Perinatol       Date:  2002 Jul-Aug       Impact factor: 2.521

10.  [Amniotic band syndrome: pathogenesis, prenatal diagnosis and neonatal management].

Authors:  L Sentilhes; E Verspyck; S Patrier; D Eurin; J Lechevallier; L Marpeau
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.